Data |
Ora |
Fonte |
Titolo |
03/6/2024 | 22:30 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
31/5/2024 | 14:00 | BW | Azitra, Inc. Announces Presentation at the 2024 BIO.. |
24/5/2024 | 22:55 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
17/5/2024 | 14:00 | BW | Azitra, Inc. Announces Positive Preclinical Data from ATR-04.. |
10/5/2024 | 14:00 | BW | Azitra, Inc. Announces Positive Preclinical Data of ATR-12.. |
09/5/2024 | 23:05 | EDGAR2 | Form 8-K - Current report |
09/5/2024 | 23:03 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/5/2024 | 23:00 | BW | Azitra, Inc. Announces Q1 2024 Financial Results and.. |
22/4/2024 | 22:30 | BW | Azitra, Inc. Announces New Preclinical Data to be Presented.. |
18/4/2024 | 22:15 | BW | Azitra, Inc. to Present New Data at Three Upcoming.. |
15/3/2024 | 21:15 | BW | Azitra, Inc. Announces Full Year 2023 Financial Results and.. |
26/2/2024 | 22:10 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
26/2/2024 | 22:05 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
16/2/2024 | 22:05 | BW | Azitra, Inc. Announces Closing of Public Offering |
16/2/2024 | 02:42 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
16/2/2024 | 02:39 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
16/2/2024 | 02:38 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
15/2/2024 | 22:44 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
14/2/2024 | 15:15 | EDGAR2 | Form 8-K - Current report |
14/2/2024 | 04:09 | BW | Azitra, Inc. Announces Pricing of Public Offering |
19/1/2024 | 17:08 | EDGAR2 | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
19/1/2024 | 15:19 | EDGAR2 | Form S-1 - General form for registration of securities under.. |
16/1/2024 | 15:00 | BW | Azitra, Inc. Strengthens Intellectual Property Portfolio.. |
03/1/2024 | 15:00 | BW | Azitra, Inc. to Present at Biotech Showcase 2024 and the.. |
04/12/2023 | 22:06 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
14/11/2023 | 22:30 | BW | Azitra, Inc. Announces Third Quarter 2023 Financial Results.. |
16/10/2023 | 14:00 | BW | Azitra to Present at the ThinkEquity Conference |
03/10/2023 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
03/10/2023 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
03/10/2023 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
03/10/2023 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
29/8/2023 | 14:00 | PRNUS | Azitra to Present at the H.C. Wainwright 25th Annual Global.. |
14/8/2023 | 22:11 | EDGAR2 | Form 8-K - Current report |
14/8/2023 | 22:10 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
14/8/2023 | 22:05 | PRNUS | Azitra, Inc. Announces Second Quarter 2023 Financial Results.. |
19/7/2023 | 22:05 | PRNUS | Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to.. |
11/7/2023 | 22:05 | EDGAR2 | Form 8-K - Current report |
11/7/2023 | 22:05 | PRNUS | Azitra, Inc. Appoints Travis Whitfill as Chief Operating.. |
07/7/2023 | 22:05 | EDGAR2 | Form 8-K - Current report |
03/7/2023 | 21:04 | EDGAR2 | Form SC 13D - General statement of acquisition of beneficial.. |
29/6/2023 | 22:56 | EDGAR2 | Form 4/A - Statement of changes in beneficial ownership of.. |
22/6/2023 | 00:46 | PRNUS | Azitra, Inc. Announces Closing of Initial Public Offering |
16/6/2023 | 01:04 | PRNUS | Azitra, Inc. Announces Pricing of Initial Public Offering |